Literature DB >> 18676352

Endothelium-specific interference with peroxisome proliferator activated receptor gamma causes cerebral vascular dysfunction in response to a high-fat diet.

Andreas M Beyer1, Willem J de Lange, Carmen M Halabi, Mary L Modrick, Henry L Keen, Frank M Faraci, Curt D Sigmund.   

Abstract

The ligand-activated transcription factor peroxisome proliferator activated receptor gamma (PPARgamma) is expressed in vascular endothelium where it exerts anti-inflammatory and antioxidant effects. However, its role in regulating vascular function remains undefined. We examined endothelial function in transgenic mice expressing dominant-negative mutants of PPARgamma under the control of an endothelial-specific promoter to test the hypothesis that endothelial PPARgamma plays a protective role in the vasculature. Under baseline conditions, responses to the endothelium-dependent agonist acetylcholine were not affected in either aorta or the basilar artery in vitro. In response to feeding a high-fat diet for 12 weeks, acetylcholine produced dilation that was markedly impaired in the basilar artery of mice expressing dominant-negative mutants, but not in mice expressing wild-type PPARgamma controlled by the same promoter. Unlike basilar artery, 12 weeks of a high-fat diet was not sufficient to cause endothelial dysfunction in the aorta of mice expressing dominant-negative PPARgamma, although aortic dysfunction became evident after 25 weeks. The responses to acetylcholine in basilar artery were restored to normal after treatment with a scavenger of superoxide. Baseline blood pressure was only slightly elevated in the transgenic mice, but the pressor response to angiotensin II was augmented. Thus, interference with PPARgamma in the endothelium produces endothelial dysfunction in the cerebral circulation through a mechanism involving oxidative stress. Consistent with its role as a fatty acid sensor, these findings provide genetic evidence that endothelial PPARgamma plays a critical role in protecting blood vessels in response to a high-fat diet.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18676352      PMCID: PMC2583077          DOI: 10.1161/CIRCRESAHA.108.176339

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  32 in total

1.  Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux.

Authors:  Taro E Akiyama; Shuichi Sakai; Gilles Lambert; Christopher J Nicol; Kimihiko Matsusue; Satish Pimprale; Ying-Hue Lee; Mercedes Ricote; Christopher K Glass; H Bryan Brewer; Frank J Gonzalez
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

2.  Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay.

Authors:  G Krey; O Braissant; F L'Horset; E Kalkhoven; M Perroud; M G Parker; W Wahli
Journal:  Mol Endocrinol       Date:  1997-06

3.  Superoxide levels and function of cerebral blood vessels after inhibition of CuZn-SOD.

Authors:  S P Didion; C A Hathaway; F M Faraci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-10       Impact factor: 4.733

4.  Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice.

Authors:  Sean P Didion; Michael J Ryan; Lisa A Didion; Pamela E Fegan; Curt D Sigmund; Frank M Faraci
Journal:  Circ Res       Date:  2002-11-15       Impact factor: 17.367

5.  Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter.

Authors:  Geoffrey D Girnun; Frederick E Domann; Steven A Moore; Mike E C Robbins
Journal:  Mol Endocrinol       Date:  2002-12

6.  Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma.

Authors:  Quy N Diep; Mohammed El Mabrouk; Jeffrey S Cohn; Dierk Endemann; Farhad Amiri; Agostino Virdis; Mario Fritsch Neves; Ernesto L Schiffrin
Journal:  Circulation       Date:  2002-05-14       Impact factor: 29.690

7.  Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-independent signaling pathways.

Authors:  Du-Hyong Cho; Yoon Jung Choi; Sangmee Ahn Jo; Inho Jo
Journal:  J Biol Chem       Date:  2003-10-30       Impact factor: 5.157

8.  Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma.

Authors:  Yau-Sheng Tsai; Hyo-Jeong Kim; Nobuyuki Takahashi; Hyung-Suk Kim; John R Hagaman; Jason K Kim; Nobuyo Maeda
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

9.  Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function.

Authors:  H Satoh; K Tsukamoto; Y Hashimoto; N Hashimoto; M Togo; M Hara; H Maekawa; N Isoo; S Kimura; T Watanabe
Journal:  Biochem Biophys Res Commun       Date:  1999-01-27       Impact factor: 3.575

10.  PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice.

Authors:  Michael J Ryan; Sean P Didion; Satya Mathur; Frank M Faraci; Curt D Sigmund
Journal:  Hypertension       Date:  2004-01-26       Impact factor: 10.190

View more
  57 in total

Review 1.  Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease.

Authors:  Karima Ait-Aissa; Johnathan D Ebben; Andrew O Kadlec; Andreas M Beyer
Journal:  Pharmacol Res       Date:  2016-07-06       Impact factor: 7.658

2.  Endothelial PPARγ (Peroxisome Proliferator-Activated Receptor-γ) Is Essential for Preventing Endothelial Dysfunction With Aging.

Authors:  T Michael De Silva; Ying Li; Dale A Kinzenbaw; Curt D Sigmund; Frank M Faraci
Journal:  Hypertension       Date:  2018-05-07       Impact factor: 10.190

3.  Surviving the remodel: the impact of hypertension during pregnancy.

Authors:  Frank M Faraci
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

4.  Biomechanical Forces and Oxidative Stress: Implications for Pulmonary Vascular Disease.

Authors:  Evgeny A Zemskov; Qing Lu; Wojciech Ornatowski; Christina N Klinger; Ankit A Desai; Emin Maltepe; Jason X-J Yuan; Ting Wang; Jeffrey R Fineman; Stephen M Black
Journal:  Antioxid Redox Signal       Date:  2019-03-19       Impact factor: 8.401

Review 5.  Endothelial PPARγ Is Crucial for Averting Age-Related Vascular Dysfunction by Stalling Oxidative Stress and ROCK.

Authors:  Md Sahab Uddin; Md Tanvir Kabir; Md Jakaria; Abdullah Al Mamun; Kamal Niaz; Md Shah Amran; George E Barreto; Ghulam Md Ashraf
Journal:  Neurotox Res       Date:  2019-05-04       Impact factor: 3.911

Review 6.  The adaptation of the cerebral circulation to pregnancy: mechanisms and consequences.

Authors:  Marilyn J Cipolla
Journal:  J Cereb Blood Flow Metab       Date:  2013-01-16       Impact factor: 6.200

7.  Smooth Muscle Peroxisome Proliferator-Activated Receptor γ Plays a Critical Role in Formation and Rupture of Cerebral Aneurysms in Mice In Vivo.

Authors:  David M Hasan; Robert M Starke; He Gu; Katina Wilson; Yi Chu; Nohra Chalouhi; Donald D Heistad; Frank M Faraci; Curt D Sigmund
Journal:  Hypertension       Date:  2015-04-27       Impact factor: 10.190

8.  Bioinformatic analysis of gene sets regulated by ligand-activated and dominant-negative peroxisome proliferator-activated receptor gamma in mouse aorta.

Authors:  Henry L Keen; Carmen M Halabi; Andreas M Beyer; Willem J de Lange; Xuebo Liu; Nobuyo Maeda; Frank M Faraci; Thomas L Casavant; Curt D Sigmund
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-12-17       Impact factor: 8.311

9.  Interference With Endothelial PPAR (Peroxisome Proliferator-Activated Receptor)-γ Causes Accelerated Cerebral Vascular Dysfunction in Response to Endogenous Renin-Angiotensin System Activation.

Authors:  Anand R Nair; Larry N Agbor; Masashi Mukohda; Xuebo Liu; Chunyan Hu; Jing Wu; Curt D Sigmund
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

10.  Effect of selective expression of dominant-negative PPARγ in pro-opiomelanocortin neurons on the control of energy balance.

Authors:  Madeliene Stump; Deng-Fu Guo; Ko-Ting Lu; Masashi Mukohda; Xuebo Liu; Kamal Rahmouni; Curt D Sigmund
Journal:  Physiol Genomics       Date:  2016-05-13       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.